S100A16 and renal carcinoma: Fluorescence quantitative PCR results demonstrated that the transfection of shRNA-S100A16 substantially inhibited the expression level of S100A16.0 mRNA in renal cancer 796-P cells compared with the control group (shRNA-control; Figure 8(b)).